Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

After the Removal Syringe: Novo Nordisk Now Takes Drugs against...

Summary by Die Presse
The Ozempic and Wegovy manufacturer is looking for new growth areas beyond diabetes and obesity. The treatment of hair loss is also in focus – a market in which Novo Nordisk could use both its hormone expertise and direct distribution to patients.

1 Articles

Die PresseDie Presse
Lean Right

After the Removal Syringe: Novo Nordisk Now Takes Drugs against...

The Ozempic and Wegovy manufacturer is looking for new growth areas beyond diabetes and obesity. The treatment of hair loss is also in focus – a market in which Novo Nordisk could use both its hormone expertise and direct distribution to patients.

·Vienna, Austria
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Die Presse broke the news in Vienna, Austria on Wednesday, September 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Diabetes icon

Diabetes

Novo Nordisk icon

Novo Nordisk

Ozempic icon

Ozempic

Vienna, Austria icon

Vienna, Austria

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal